Lazomis QI

Welcome to Lazomis QI

Clinician-focused audit and quality improvement workspace, scoped to your organisation.

Browse toolsOpen data collection
Active projects
0
Diabetes Medication Review in Acute Illness Audit
Submissions
0
0 draft
Overall compliance
0%
Target 90% (audit standard)
Sick-day guidance
0%
Cases where considered

Diabetes Medication Review in Acute Illness Audit

Baseline Audit · Cycle 1 · NICE NG28 (Type 2 diabetes in adults)

Audit compliance with medication review and appropriate adjustment of diabetes therapies during acute illness to support safe prescribing and reduce medication-related harm.

Project overviewProject dashboardSubmissionsExport centre

Quick actions

Common tasks across the workspace

Browse tool library Configure your project Manage project team Admin console

Clinical safety

Standing principles for every Lazomis tool

  • This tool supports, but does not replace, clinical judgement.
  • Local policy, formulary and specialist advice should be followed.
  • Use anonymised or pseudonymised audit identifiers wherever possible.
  • Data is organisation-scoped with row-level security on every table.